Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.87
+0.57 (6.87%)
At close: Apr 28, 2026, 4:00 PM EDT
8.83
-0.04 (-0.43%)
After-hours: Apr 28, 2026, 4:53 PM EDT
ARCT Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ARCT stock have an average target of 24.11, with a low estimate of 8.00 and a high estimate of 54. The average target predicts an increase of 171.82% from the current stock price of 8.87.
Analyst Consensus: Buy
* Price targets were last updated on Mar 18, 2026.
Analyst Ratings
The average analyst rating for ARCT stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 3 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Initiates $22 | Hold → Strong Buy | Initiates | $22 | +148.03% | Mar 18, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $66 → $21 | Strong Buy | Maintains | $66 → $21 | +136.75% | Mar 5, 2026 |
| Citigroup | Citigroup | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | -9.81% | Mar 4, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $72 → $25 | Buy | Maintains | $72 → $25 | +181.85% | Mar 4, 2026 |
| Citigroup | Citigroup | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | -21.08% | Jan 6, 2026 |
Financial Forecast
Revenue This Year
41.05M
from 82.03M
Decreased by -49.96%
Revenue Next Year
46.29M
from 41.05M
Increased by 12.77%
EPS This Year
-4.58
from -2.40
EPS Next Year
-4.57
from -4.58
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 182.6M | 160.6M | ||||||
| Avg | 41.1M | 46.3M | ||||||
| Low | 14.9M | 13.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 122.6% | 291.1% | ||||||
| Avg | -50.0% | 12.8% | ||||||
| Low | -81.9% | -68.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.47 | -3.38 | ||||||
| Avg | -4.58 | -4.57 | ||||||
| Low | -5.39 | -5.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.